220 related articles for article (PubMed ID: 32832569)
21. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
22. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
23.
Gu Z; Pei W; Shen Y; Wang L; Zhu J; Zhang Y; Fan S; Wu Q; Li L; Zhang Z
Food Funct; 2021 Oct; 12(20):10184-10195. PubMed ID: 34532729
[TBL] [Abstract][Full Text] [Related]
24. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
25. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
26. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
27. Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.
Huang X; Huang G; Song H; Chen L
Int J Cancer; 2011 Aug; 129(3):648-58. PubMed ID: 20878978
[TBL] [Abstract][Full Text] [Related]
28. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.
Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y
Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922
[TBL] [Abstract][Full Text] [Related]
29. [Qiyusanlong decoction inhibits the level of PD-1/PD-L1 in mice bearing Lewis lung carcinoma].
Zhang X; Tong J; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):770-4. PubMed ID: 27371844
[TBL] [Abstract][Full Text] [Related]
30. Influence of oral administration of Akkermansia muciniphila on the tissue distribution and gut microbiota composition of acute and chronic cadmium exposure mice.
Feng S; Liu Y; Huang Y; Zhao J; Zhang H; Zhai Q; Chen W
FEMS Microbiol Lett; 2019 Jul; 366(13):. PubMed ID: 31310663
[TBL] [Abstract][Full Text] [Related]
31. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation.
Sun Y; Yang J; Yang T; Li Y; Zhu R; Hou Y; Liu Y
Acta Biomater; 2021 Jul; 128():447-461. PubMed ID: 33894351
[TBL] [Abstract][Full Text] [Related]
32. Untargeted metabolomics analysis of omeprazole-enhanced chemosensitivity to cisplatin in mice with non-small cell lung cancer.
Gao H; Song Y; Ma J; Zhai J; Zhang Y; Qu X
Chem Biol Interact; 2022 Jun; 360():109933. PubMed ID: 35447140
[TBL] [Abstract][Full Text] [Related]
33. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
34. Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.
Johnson CS; Chang MJ; Yu WD; Modzelewski RA; Grandis JR; Vlock DR; Furmanski P
Cancer Chemother Pharmacol; 1993; 32(5):339-46. PubMed ID: 8339383
[TBL] [Abstract][Full Text] [Related]
35. Oral administration of
Grajeda-Iglesias C; Durand S; Daillère R; Iribarren K; Lemaitre F; Derosa L; Aprahamian F; Bossut N; Nirmalathasan N; Madeo F; Zitvogel L; Kroemer G
Aging (Albany NY); 2021 Mar; 13(5):6375-6405. PubMed ID: 33653967
[TBL] [Abstract][Full Text] [Related]
36. Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatment.
Fokkema E; De Vries EG; Groen HJ; Meijer C; Timens W
Virchows Arch; 2003 Apr; 442(4):349-55. PubMed ID: 12715170
[TBL] [Abstract][Full Text] [Related]
37. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin-loaded polymeric complex micelles with a modulated drug/copolymer ratio for improved in vivo performance.
Chen Q; Luo L; Xue Y; Han J; Liu Y; Zhang Y; Yin T; Wang L; Cun D; Gou J; He H; Tang X
Acta Biomater; 2019 Jul; 92():205-218. PubMed ID: 31071475
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
Bai L; Wang A; Zhang Y; Xu X; Zhang X
Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice].
Hou JM; Liu JY; Yang L; Zhao X; Tian L; Lei S; Mao YQ; Wen YJ; Wei YQ
Ai Zheng; 2005 Apr; 24(4):391-6. PubMed ID: 15820058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
